Bortezomib-induced acute pancreatitis in a patient with multiple myeloma

By Wang He-Hua   Tsui James   Wang Xiao-Yan   Liu Shou-Sheng   Li Juan  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1404-1405

Informa Healthcare

Access to resources Recommend Favorite

Current Therapeutic Strategy for Multiple Myeloma

By Suzuki Kenshi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 2, 2013-02 ,pp. : 116-124

Oxford University Press

Access to resources Recommend Favorite

Complete remission of multiple myeloma associated scleredema after bortezomib-based treatment

By Szturz Petr  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1324-1326

Informa Healthcare

Access to resources Recommend Favorite

Intravenous injection of bortezomib, melphalan and dexamethasone in refractory and relapsed multiple myeloma

By Romano A.   Chiarenza A.   Consoli U.   Conticello C.   Forte S.   Uccello G.   Vetro C.   Cavalli M.   Coppolino F.   Palumbo G. A.   Di Raimondo F.  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1038-1044

Oxford University Press

Access to resources Recommend Favorite

Dyclonine enhances the cytotoxic effect of proteasome inhibitor bortezomib in multiple myeloma cells

By    

Molecular Medicine Reports, Vol. 10, Iss. 5, 2014-01 ,pp. : 2609-2612

Spandidos Publications

Access to resources Recommend Favorite